Oramed Adds Two New Members to its Scientific Advisory Board

NEW YORK, Feb. 28, 2018  /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today the additions of Drs. Robert Henry and Jane Reusch to its Scientific Advisory Board. Dr. Henry is a leader in diabetes research. As a past […]